ID   ATLA3_HUMAN             Reviewed;         541 AA.
AC   Q6DD88; Q8N7W5; Q9H8Q5; Q9UFL1;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 1.
DT   07-APR-2021, entry version 138.
DE   RecName: Full=Atlastin-3;
DE            EC=3.6.5.-;
GN   Name=ATL3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   IDENTIFICATION.
RX   PubMed=14506257; DOI=10.1074/jbc.m306702200;
RA   Zhu P.-P., Patterson A., Lavoie B., Stadler J., Shoeb M., Patel R.,
RA   Blackstone C.;
RT   "Cellular localization, oligomerization, and membrane association of the
RT   hereditary spastic paraplegia 3A (SPG3A) protein atlastin.";
RL   J. Biol. Chem. 278:49063-49071(2003).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-535, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   FUNCTION, TOPOLOGY, SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-73 AND
RP   ARG-213, AND TISSUE SPECIFICITY.
RX   PubMed=18270207; DOI=10.1093/hmg/ddn046;
RA   Rismanchi N., Soderblom C., Stadler J., Zhu P.-P., Blackstone C.;
RT   "Atlastin GTPases are required for Golgi apparatus and ER morphogenesis.";
RL   Hum. Mol. Genet. 17:1591-1604(2008).
RN   [7]
RP   FUNCTION.
RX   PubMed=19665976; DOI=10.1016/j.cell.2009.05.025;
RA   Hu J., Shibata Y., Zhu P.-P., Voss C., Rismanchi N., Prinz W.A.,
RA   Rapoport T.A., Blackstone C.;
RT   "A class of dynamin-like GTPases involved in the generation of the tubular
RT   ER network.";
RL   Cell 138:549-561(2009).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-391, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-535, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH ZFYVE27.
RX   PubMed=23969831; DOI=10.1073/pnas.1307391110;
RA   Chang J., Lee S., Blackstone C.;
RT   "Protrudin binds atlastins and endoplasmic reticulum-shaping proteins and
RT   regulates network formation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:14954-14959(2013).
RN   [12]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, VARIANT HSN1F CYS-192, AND
RP   CHARACTERIZATION OF VARIANT HSN1F CYS-192.
RX   PubMed=24459106; DOI=10.1093/brain/awt357;
RA   Kornak U., Mademan I., Schinke M., Voigt M., Krawitz P., Hecht J.,
RA   Barvencik F., Schinke T., Giesselmann S., Beil F.T., Pou-Serradell A.,
RA   Vilchez J.J., Beetz C., Deconinck T., Timmerman V., Kaether C.,
RA   De Jonghe P., Huebner C.A., Gal A., Amling M., Mundlos S., Baets J.,
RA   Kurth I.;
RT   "Sensory neuropathy with bone destruction due to a mutation in the
RT   membrane-shaping atlastin GTPase 3.";
RL   Brain 137:683-692(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF LYS-73 AND ARG-213.
RX   PubMed=27619977; DOI=10.7554/elife.18605;
RA   Wang S., Tukachinsky H., Romano F.B., Rapoport T.A.;
RT   "Cooperation of the ER-shaping proteins atlastin, lunapark, and reticulons
RT   to generate a tubular membrane network.";
RL   Elife 5:0-0(2016).
CC   -!- FUNCTION: GTPase tethering membranes through formation of trans-
CC       homooligomers and mediating homotypic fusion of endoplasmic reticulum
CC       membranes. Functions in endoplasmic reticulum tubular network
CC       biogenesis (PubMed:18270207, PubMed:19665976, PubMed:27619977).
CC       {ECO:0000269|PubMed:18270207, ECO:0000269|PubMed:19665976,
CC       ECO:0000269|PubMed:27619977}.
CC   -!- SUBUNIT: Interacts with ZFYVE27 (PubMed:23969831).
CC       {ECO:0000269|PubMed:23969831}.
CC   -!- INTERACTION:
CC       Q6DD88; Q5T4F4: ZFYVE27; NbExp=3; IntAct=EBI-6165882, EBI-3892947;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:18270207, ECO:0000269|PubMed:24459106,
CC       ECO:0000269|PubMed:27619977}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:18270207, ECO:0000269|PubMed:24459106}.
CC       Note=Localizes to endoplasmic reticulum tubules and accumulates in
CC       punctuate structures corresponding to 3-way junctions, which represent
CC       crossing-points at which the tubules build a polygonal network.
CC       {ECO:0000269|PubMed:23969831, ECO:0000269|PubMed:24459106,
CC       ECO:0000269|PubMed:27619977}.
CC   -!- TISSUE SPECIFICITY: Expressed in the central nervous system and in
CC       dorsal root ganglia neurons. Expressed in peripheral tissues (at
CC       protein level). {ECO:0000269|PubMed:18270207,
CC       ECO:0000269|PubMed:24459106}.
CC   -!- DISEASE: Neuropathy, hereditary sensory, 1F (HSN1F) [MIM:615632]: An
CC       autosomal dominant sensory neuropathy affecting the lower limbs. Distal
CC       sensory impairment becomes apparent during the second or third decade
CC       of life, resulting in painless ulceration of the feet with poor
CC       healing, which can progress to osteomyelitis, bone destruction, and
CC       amputation. There is no autonomic involvement, spasticity, or cognitive
CC       impairment. {ECO:0000269|PubMed:24459106}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. GB1/RHD3 GTPase family. GB1 subfamily.
CC       {ECO:0000255|PROSITE-ProRule:PRU01052}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC05111.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK097588; BAC05111.1; ALT_SEQ; mRNA.
DR   EMBL; AK023383; BAB14552.1; -; mRNA.
DR   EMBL; AL117600; CAB56010.2; -; mRNA.
DR   EMBL; BC077727; AAH77727.1; -; mRNA.
DR   CCDS; CCDS41663.1; -.
DR   PIR; T17320; T17320.
DR   RefSeq; NP_001276977.1; NM_001290048.1.
DR   RefSeq; NP_056274.3; NM_015459.4.
DR   PDB; 5VGR; X-ray; 2.10 A; A/B=21-442.
DR   PDBsum; 5VGR; -.
DR   SMR; Q6DD88; -.
DR   BioGRID; 117423; 103.
DR   CORUM; Q6DD88; -.
DR   IntAct; Q6DD88; 76.
DR   MINT; Q6DD88; -.
DR   STRING; 9606.ENSP00000381844; -.
DR   TCDB; 9.B.390.1.2; the tmcc/tex28 (tm-tex) family.
DR   GlyGen; Q6DD88; 1 site.
DR   iPTMnet; Q6DD88; -.
DR   MetOSite; Q6DD88; -.
DR   PhosphoSitePlus; Q6DD88; -.
DR   SwissPalm; Q6DD88; -.
DR   BioMuta; ATL3; -.
DR   DMDM; 74736374; -.
DR   EPD; Q6DD88; -.
DR   jPOST; Q6DD88; -.
DR   MassIVE; Q6DD88; -.
DR   MaxQB; Q6DD88; -.
DR   PaxDb; Q6DD88; -.
DR   PeptideAtlas; Q6DD88; -.
DR   PRIDE; Q6DD88; -.
DR   ProteomicsDB; 66223; -.
DR   TopDownProteomics; Q6DD88; -.
DR   Antibodypedia; 28987; 227 antibodies.
DR   Ensembl; ENST00000398868; ENSP00000381844; ENSG00000184743.
DR   GeneID; 25923; -.
DR   KEGG; hsa:25923; -.
DR   UCSC; uc001nxk.2; human.
DR   CTD; 25923; -.
DR   DisGeNET; 25923; -.
DR   GeneCards; ATL3; -.
DR   HGNC; HGNC:24526; ATL3.
DR   HPA; ENSG00000184743; Low tissue specificity.
DR   MalaCards; ATL3; -.
DR   MIM; 609369; gene.
DR   MIM; 615632; phenotype.
DR   neXtProt; NX_Q6DD88; -.
DR   OpenTargets; ENSG00000184743; -.
DR   Orphanet; 36386; Hereditary sensory and autonomic neuropathy type 1.
DR   PharmGKB; PA164716353; -.
DR   VEuPathDB; HostDB:ENSG00000184743.12; -.
DR   eggNOG; KOG2037; Eukaryota.
DR   GeneTree; ENSGT00940000158566; -.
DR   InParanoid; Q6DD88; -.
DR   OMA; QYYKNME; -.
DR   OrthoDB; 1027269at2759; -.
DR   PhylomeDB; Q6DD88; -.
DR   TreeFam; TF105251; -.
DR   PathwayCommons; Q6DD88; -.
DR   BioGRID-ORCS; 25923; 16 hits in 999 CRISPR screens.
DR   ChiTaRS; ATL3; human.
DR   GenomeRNAi; 25923; -.
DR   Pharos; Q6DD88; Tbio.
DR   PRO; PR:Q6DD88; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q6DD88; protein.
DR   Bgee; ENSG00000184743; Expressed in layer of synovial tissue and 225 other tissues.
DR   ExpressionAtlas; Q6DD88; baseline and differential.
DR   Genevisible; Q6DD88; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0071782; C:endoplasmic reticulum tubular network; IDA:UniProtKB.
DR   GO; GO:0098826; C:endoplasmic reticulum tubular network membrane; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IBA:GO_Central.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IDA:UniProtKB.
DR   GO; GO:0007029; P:endoplasmic reticulum organization; IMP:UniProtKB.
DR   GO; GO:0007030; P:Golgi organization; IMP:UniProtKB.
DR   GO; GO:1903373; P:positive regulation of endoplasmic reticulum tubular network organization; IMP:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   InterPro; IPR030386; G_GB1_RHD3_dom.
DR   InterPro; IPR003191; Guanylate-bd/ATL_C.
DR   InterPro; IPR036543; Guanylate-bd_C_sf.
DR   InterPro; IPR015894; Guanylate-bd_N.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF02263; GBP; 1.
DR   Pfam; PF02841; GBP_C; 1.
DR   SUPFAM; SSF48340; SSF48340; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51715; G_GB1_RHD3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Coiled coil; Disease variant;
KW   Endoplasmic reticulum; GTP-binding; Hydrolase; Membrane; Neuropathy;
KW   Nucleotide-binding; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..541
FT                   /note="Atlastin-3"
FT                   /id="PRO_0000287109"
FT   TOPO_DOM        1..445
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:18270207"
FT   TRANSMEM        446..466
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        467
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        468..488
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        489..541
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:18270207"
FT   DOMAIN          57..305
FT                   /note="GB1/RHD3-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01052"
FT   NP_BIND         67..74
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         114..116
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         213..214
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         272..275
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         391
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         535
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:23186163"
FT   VARIANT         192
FT                   /note="Y -> C (in HSN1F; causes mislocalization of the
FT                   protein; the mutant protein accumulates in condensed
FT                   structures near the nucleus and localizes to unbranched
FT                   tubules; has a dominant-negative disruptive effect on the
FT                   regular structure of the endoplasmic reticulum;
FT                   dbSNP:rs587777108)"
FT                   /evidence="ECO:0000269|PubMed:24459106"
FT                   /id="VAR_070973"
FT   MUTAGEN         73
FT                   /note="K->A: Alters endoplasmic reticulum morphogenesis."
FT                   /evidence="ECO:0000269|PubMed:18270207,
FT                   ECO:0000269|PubMed:27619977"
FT   MUTAGEN         213
FT                   /note="R->Q: Alters endoplasmic reticulum morphogenesis."
FT                   /evidence="ECO:0000269|PubMed:18270207,
FT                   ECO:0000269|PubMed:27619977"
FT   CONFLICT        49
FT                   /note="I -> T (in Ref. 1; BAB14552)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        158
FT                   /note="T -> A (in Ref. 2; CAB56010)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        173
FT                   /note="N -> S (in Ref. 1; BAC05111)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        202
FT                   /note="Q -> R (in Ref. 2; CAB56010)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        215
FT                   /note="W -> R (in Ref. 2; CAB56010)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        351
FT                   /note="N -> Y (in Ref. 2; CAB56010)"
FT                   /evidence="ECO:0000305"
FT   STRAND          26..31
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           43..50
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   TURN            53..57
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   STRAND          58..68
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           73..88
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   STRAND          111..113
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   STRAND          118..123
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   STRAND          126..129
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   STRAND          135..145
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           157..166
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   STRAND          168..177
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           180..184
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           187..200
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   STRAND          204..213
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   TURN            218..220
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           225..235
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           244..250
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           253..256
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   STRAND          257..264
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           270..273
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           282..284
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           287..301
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   TURN            303..305
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           318..331
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   STRAND          334..336
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           340..371
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           380..400
FT                   /evidence="ECO:0007744|PDB:5VGR"
FT   HELIX           407..434
FT                   /evidence="ECO:0007744|PDB:5VGR"
SQ   SEQUENCE   541 AA;  60542 MW;  E5C58A53F93B42D0 CRC64;
     MLSPQRVAAA ASRGADDAME SSKPGPVQVV LVQKDQHSFE LDEKALASIL LQDHIRDLDV
     VVVSVAGAFR KGKSFILDFM LRYLYSQKES GHSNWLGDPE EPLTGFSWRG GSDPETTGIQ
     IWSEVFTVEK PGGKKVAVVL MDTQGAFDSQ STVKDCATIF ALSTMTSSVQ IYNLSQNIQE
     DDLQQLQLFT EYGRLAMDEI FQKPFQTLMF LVRDWSFPYE YSYGLQGGMA FLDKRLQVKE
     HQHEEIQNVR NHIHSCFSDV TCFLLPHPGL QVATSPDFDG KLKDIAGEFK EQLQALIPYV
     LNPSKLMEKE INGSKVTCRG LLEYFKAYIK IYQGEDLPHP KSMLQATAEA NNLAAAASAK
     DIYYNNMEEV CGGEKPYLSP DILEEKHCEF KQLALDHFKK TKKMGGKDFS FRYQQELEEE
     IKELYENFCK HNGSKNVFST FRTPAVLFTG IVALYIASGL TGFIGLEVVA QLFNCMVGLL
     LIALLTWGYI RYSGQYRELG GAIDFGAAYV LEQASSHIGN STQATVRDAV VGRPSMDKKA
     Q
//
